Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Narcotic antagonists

Naloxone nasal spray shows potential for opioid-overdose reversal

A study of nasally administered opioid antagonist, naloxone, has shown promising results

Naloxone nasal spray

Source: Tribune Content Agency LLC / Alamy Stock Photo

Study results support the potential of naloxone nasal spray as an alternative to injectable naloxone devices for opioid-overdose reversal 

Naloxone is a powerful opioid antagonist that can reverse overdose from drugs such as heroin. Naloxone nasal sprays have been developed as an alternative to injectable naloxone devices. However, there are only limited pharmacokinetic data on the bioavailability of nasally administered naloxone.

In a paper in Addiction (16 November 2017), researchers administered 38 healthy volunteers with 5 different doses of naloxone: 1mg, 2mg and 4mg intranasally; 0.4mg intramuscularly; and 0.4mg intravenously[1].

They found that all intranasal doses resulted in dose-dependent blood plasma naloxone levels that peaked within 15–30 minutes. The 2mg intranasal dose most closely mimicked early blood concentrations of the standard intramuscular dose (0.4mg) in the 10 minutes post-dosing and maintained higher plateau levels for 2 hours after.

The team said the results support the potential of naloxone nasal spray for opioid-overdose reversal, but further research is needed to test administration in people with opioid-use disorders.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204213

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Naloxone nasal spray

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.